General Considerations The most common etiologic agents of VL are 3 species of the L. donovani complex: Leishmania donovani donovani and Leishmania donovani infantum in the Indian subcontinent, Africa, China, the Mediterranean littoral, and the Middle East; and Leishmania donovani chagasi in South America. (Hereafter, organisms will be identified only by genus and species; eg, L. donovani for L...

OBJECTIVES We investigated potential microenvironmental risk factors for visceral leishmaniasis in urban and suburban areas, and developed risk scores to characterize the household and the neighborhood. These scores may be useful to identify microenvironments within cities that place residents at greater risk of visceral leishmaniasis. METHODS In this case-control study, cases were all person...

Post kala-azar dermal leishmaniasis (PKDL) is a non-ulcerative lesion of the skin caused by Leishmania donovani, which is usually seen after completion of treatment of the kala-azar. The condition is yet to be reported from Nepal. We document and report for the first time a case of PKDL in Nepal.

OBJECTIVE To compare the clinical and laboratorial data before and after the treatment of patients with visceral leishmaniasis admitted to a pediatric hospital in a nonendemic area, highlighting the importance of recognizing visceral leishmaniasis in pediatric patients. METHODS Clinical, laboratorial and treatment data of 78 patients with visceral leishmaniasis were evaluated from 1981 to 199...

OBJECTIVE This study aimed to determine whether anti-rK39 antibodies were diagnostic markers for visceral leishmaniasis (kala-azar) and to evaluate the correlation between age and gender in disease occurrence in Iraqi patients. In addition, it aimed to evaluate the correlation between thyroid hormones, i.e., thyroid-stimulating hormone (TSH), triiodothyronine (T3), and thyroxine (T4) and anti-r...

Visceral leishmaniasis (VL) is endemic in the island of São Luis, State of Maranhão, Brazil. Despite an increase in the number of VL cases, the frequency of the disease is low among pregnant women. We present here the case of a pregnant woman followed up by our group, who was treated with amphotericin B with excellent outcome.

conclusions development of novel drugs and diagnostic tests has allowed us to better manage vl. although leishmaniasis is one of the oldest known parasitic infectious diseases, increasing prevalence of vl among specific populations, recent reports of disease reactivation and flare-up in clinically asymptomatic patients after the onset of immunosuppressive therapy, the risk of disease acquisitio...

leishmaniasis (vl) is a life-threatening vector-borne parasitic disease is distribut-ed in some parts of the new world and old world. the disease is endemic in different parts of iran. this review article has been focused on major topics of epidemiological aspects and clinical features of vl in iran for the period of 2002 through 2012. for the detection of vl in humans as well as animal reservo...

background: the causative agent of visceral leishmaniasis (vl) in iran is leishmania infantum (l. infantum) (mediterranean type) and its major reservoir host is the dog. ob-jective: to compare the serological methods including direct agglutination test (dat), indirect immunofluorescent-antibody test (ifa) and enzyme-linked immunosorbent as-say (elisa) for serodiagnosis of endemic strain of l. i...

This case report describes an atypical clinical presentation of visceral leishmaniasis affecting the digestive tract and causing malabsorption syndrome in a patient without recognized immunosuppressive condition. After appropriate treatment for the classical visceral form of the disease, diarrhea persisted as the main symptom and massive infection by Leishmania was detected by histopathology an...